BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1851891)

  • 21. Single-nucleotide polymorphism in WT1 gene in a hyperplastic intralobar nephrogenic rest with botryoid protrusion.
    Mizuno K; Hayashi Y; Tozawa K; Iwatsuki S; Kojima Y; Kohri K
    Urology; 2010 Jul; 76(1):149-52. PubMed ID: 19914700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.
    Breslow NE; Beckwith JB; Perlman EJ; Reeve AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):260-7. PubMed ID: 16700047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse hyperplastic perilobar nephroblastomatosis.
    Vicens J; Iotti A; Lombardi MG; Iotti R; de Davila MT
    Pediatr Dev Pathol; 2009; 12(3):237-8. PubMed ID: 18597570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral Wilms tumor. Review of outcome, associated abnormalities, and late effects in 36 pediatric patients treated at a single institution.
    Shearer P; Parham DM; Fontanesi J; Kumar M; Lobe TE; Fairclough D; Douglass EC; Wilimas J
    Cancer; 1993 Aug; 72(4):1422-6. PubMed ID: 8393375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelotyping nephrogenic rests: putative precursor lesions of Wilms tumors.
    Maitra A; Salahuddin S; Timmons CF; Gazdar AF
    Pediatr Dev Pathol; 1999; 2(5):488-9. PubMed ID: 10441628
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidemiology of Wilms tumor.
    Breslow N; Olshan A; Beckwith JB; Green DM
    Med Pediatr Oncol; 1993; 21(3):172-81. PubMed ID: 7680412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome).
    Jadresic L; Leake J; Gordon I; Dillon MJ; Grant DB; Pritchard J; Risdon RA; Barratt TM
    J Pediatr; 1990 Nov; 117(5):717-25. PubMed ID: 2172500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial androgen receptor deficiency and mixed gonadal dysgenesis in Drash syndrome.
    Turleau C; Niaudet P; Sultan C; Rault G; Mahfoud A; Nihoul-Fekete C; Iris L; de Grouchy J
    Hum Genet; 1987 Jan; 75(1):81-3. PubMed ID: 3026952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.
    Lange J; Peterson SM; Takashima JR; Grigoriev Y; Ritchey ML; Shamberger RC; Beckwith JB; Perlman E; Green DM; Breslow NE
    J Urol; 2011 Aug; 186(2):378-86. PubMed ID: 21683387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bloom syndrome in sibs: first reports of hepatocellular carcinoma and Wilms tumor with documented anaplasia and nephrogenic rests.
    Jain D; Hui P; McNamara J; Schwartz D; German J; Reyes-Múgica M
    Pediatr Dev Pathol; 2001; 4(6):585-9. PubMed ID: 11826367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete and incomplete Drash syndrome: a clinicopathologic study of five cases of a dysontogenetic-neoplastic complex.
    Manivel JC; Sibley RK; Dehner LP
    Hum Pathol; 1987 Jan; 18(1):80-9. PubMed ID: 3028928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perilobar nephrogenic rests and chromosome 22.
    Mdzin R; Phillips M; Edwards C; Murch A; Charles A
    Pediatr Dev Pathol; 2011; 14(6):485-92. PubMed ID: 21864120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
    Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
    Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WAGR, Sex Reversal, Bilateral Gonadoblastomas, and Intralobar Nephrogenic Rests: Uncertainties of Pre-Biopsy Chemotherapy in a High Risk Syndrome for Nephroblastoma.
    Craver R; Stark M; Moss S; Long S; Prasad P; C Roth C
    Fetal Pediatr Pathol; 2023 Feb; 42(1):63-71. PubMed ID: 35199613
    [No Abstract]   [Full Text] [Related]  

  • 38. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
    Muir TE; Cheville JC; Lager DJ
    Am J Surg Pathol; 2001 Oct; 25(10):1290-6. PubMed ID: 11688464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrogenic rest associated with a mesoblastic nephroma--what does it tell us?
    Vujanić GM; Sandstedt B; Dijoud F; Harms D; Delemarre JF
    Pediatr Pathol Lab Med; 1995; 15(3):469-75. PubMed ID: 8597834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity at 11p13 and 11p15 in Wilms tumor: a study of 22 cases from India.
    Sigamani E; Wari MN; Iyer VK; Agarwala S; Sharma A; Bakhshi S; Dinda A
    Pediatr Surg Int; 2013 Mar; 29(3):223-7. PubMed ID: 23292539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.